跳至主要内容
临床试验/ACTRN12609000007235
ACTRN12609000007235终止不适用

In female adolescents with anorexia nervosa, does supplementation with L-tyrosine, when compared with usual treatment alone, lead to improvements in eating disorders psychopathology?

Dr Kenneth Nunn0 个研究点目标入组 34 人开始时间: 2009年1月7日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
12 Years 至 18 Years(—)
性别
Female

入选标准

  • Female adolescents with anorexia nervosa

排除标准

  • males, children (< 12 years) and adults (18 years and over), those with current (or within 6 months) drug or alcohol abuse, use of dietary tyrosine (or other amino acid) supplements within the previous 12 weeks, medically unstable patients, those with concurrent severe medical or neurological illness and participants with Phenylketonuria (inability to convert phenylalanine to tyrosine) and participants requiring noradrenergic or combined noradrenergic medications

研究者

发起方
Dr Kenneth Nunn

相似试验